Go to:
Logótipo
Você está em: Start > Publications > View > Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis
Map of Premises
Principal
Publication

Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis

Title
Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis
Type
Article in International Scientific Journal
Year
2006
Authors
Joana Guimaraes
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Cardoso, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Sá, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 12
Pages: 354-356
ISSN: 1352-4585
Publisher: SAGE
Other information
Authenticus ID: P-00J-0JQ
Abstract (EN): Background The descriptions of early axonal damage in patients with multiple sclerosis (MS) prompted the search of body fluid markers. However, the studies addressing this issue in MS present conflicting results. Aim To assess the levels of tau protein in patients with definite MS. Patients and methods Cerebrospinal fluid (CSF) samples from 50 patients with definite diagnosis of MS (33 F, 17 M; mean age: 33.6 years) and from 19 age-matched individuals without organic neurological diseases (11 F, 8 M), entered this study. With regard to the clinical course, the MS patients were classified as follows: 32 relapsing-remitting (RR); two secondary progressive (SP), and four primary progressive (PP). Twelve patients had clinical isolated syndromes (CIS). The mean duration was 36.1 months (range: 15 days to 20 years). Tau protein was measured in the CSF by double antibody sandwich ELISA. Results The median tau and the cut-off values of the controls were 104.9 and 175.3 pg/mL, respectively. We found that most MS patients presented normal values. In addition, the clinical features - course, duration, Expanded Disability Status Scale (EDSS) value, Poser index of progression, Multiple Sclerosis Severity Score - did not significantly influence the tau levels in the MS group. Conclusion Our study showed similar CSF tau concentrations in MS patients with different clinical characteristics. This suggests that tau protein does not seem to be a useful routine clinical marker of axonal damage.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 3
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

The role of PTPN22 1858T autoimmunity risk variant in a Portuguese multiple sclerosis population (2006)
Other Publications
pereira, c; martins da silva, a; pinto, d; bettencourt, a; costa, p; koeleman, b; martins da silva, b
Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis (2009)
Article in International Scientific Journal
Silva, AM; Bettencourt, A; Pereira, C; Santos, E; Carvalho, C; Mendonca, D; Costa, PP; Monteiro, L; Martins, B
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study (2018)
Article in International Scientific Journal
Ruano, L; Branco, M; Portaccio, E; Goretti, B; Niccolai, C; Patti, F; Chisari, C; Gallo, P; Grossi, P; Ghezzi, A; Roscio, M; Mattioli, F; Stampatori, C; Simone, M; Viterbo, RG; Amato, MP
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes (2017)
Article in International Scientific Journal
Ruano, L; Portaccio, E; Goretti, B; Niccolai, C; Severo M; Patti, F; Cilia, S; Gallo, P; Grossi, P; Ghezzi, A; Roscio, M; Mattioli, F; Stampatori, C; Trojano, M; Viterbo, RG; Amato, MP
Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-11 at 10:42:08 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book